104 related articles for article (PubMed ID: 14574629)
1. Cholesterol trafficking and amyloid beta peptides.
Wood WG; Igbavboa U
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S144-8. PubMed ID: 14574629
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol modulates amyloid beta-peptide's membrane interactions.
Eckert GP; Kirsch C; Leutz S; Wood WG; Müller WE
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S136-43. PubMed ID: 14574628
[TBL] [Abstract][Full Text] [Related]
3. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.
Xu H; Wang R; Zhang YW; Zhang X
Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779
[TBL] [Abstract][Full Text] [Related]
4. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol homeostasis failure as a unifying cause of synaptic degeneration.
Koudinov AR; Koudinova NV
J Neurol Sci; 2005 Mar; 229-230():233-40. PubMed ID: 15760645
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity.
Yip CM; Elton EA; Darabie AA; Morrison MR; McLaurin J
J Mol Biol; 2001 Aug; 311(4):723-34. PubMed ID: 11518526
[TBL] [Abstract][Full Text] [Related]
8. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?
Rauk A
Dalton Trans; 2008 Mar; (10):1273-82. PubMed ID: 18305836
[TBL] [Abstract][Full Text] [Related]
9. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease.
Zetterberg H
Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126
[TBL] [Abstract][Full Text] [Related]
10. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation.
Sastre M; Calero M; Pawlik M; Mathews PM; Kumar A; Danilov V; Schmidt SD; Nixon RA; Frangione B; Levy E
Neurobiol Aging; 2004 Sep; 25(8):1033-43. PubMed ID: 15212828
[TBL] [Abstract][Full Text] [Related]
11. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein.
Nunan J; Williamson NA; Hill AF; Sernee MF; Masters CL; Small DH
J Neurosci Res; 2003 Nov; 74(3):378-85. PubMed ID: 14598314
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease.
Blain JF; Poirier J
Expert Rev Neurother; 2004 Sep; 4(5):823-9. PubMed ID: 15853509
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide.
Butterfield DA; Bush AI
Neurobiol Aging; 2004; 25(5):563-8. PubMed ID: 15172731
[TBL] [Abstract][Full Text] [Related]
14. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
Tõugu V; Karafin A; Palumaa P
J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
[TBL] [Abstract][Full Text] [Related]
15. Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation.
Bieschke J; Zhang Q; Powers ET; Lerner RA; Kelly JW
Biochemistry; 2005 Apr; 44(13):4977-83. PubMed ID: 15794636
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
[TBL] [Abstract][Full Text] [Related]
17. Brain-membrane cholesterol in Alzheimer's disease.
Eckert GP; Kirsch C; Müller WE
J Nutr Health Aging; 2003; 7(1):18-23. PubMed ID: 12679836
[TBL] [Abstract][Full Text] [Related]
18. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.
Hama E; Saido TC
Med Hypotheses; 2005; 65(3):498-500. PubMed ID: 15921860
[TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.
Sahlin C; Pettersson FE; Nilsson LN; Lannfelt L; Johansson AS
Eur J Neurosci; 2007 Aug; 26(4):882-9. PubMed ID: 17714184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
